Short answer: The Semglee label has no missed-dose instructions in the prescribing information, Patient Information or Instructions for Use. It says Semglee is injected under the skin once daily, at any time of day but at the same time every day. Unlike Tresiba, it gives no rule for a late dose, so ask your prescriber or pharmacist what to do.
| Situation | What the label says |
|---|---|
| Schedule | Once daily, any time of day but the same time every day (2.2) |
| Missed-dose rule | None in the label |
| Forms | 10 mL vial and 3 mL prefilled pen, 100 units/mL (16.1) |
No. We checked the Semglee prescribing information, Patient Information and Instructions for Use from Biocon Biologics on DailyMed. None says what to do after a missed dose. Section 2.2: "Administer SEMGLEE subcutaneously once daily at any time of day but at the same time every day." The Patient Information: "You may take SEMGLEE at any time during the day but you must take it at the same time every day."
Semglee is approved as a biosimilar to insulin glargine, and it has its own label. Neither the Semglee nor the Lantus label has a missed-dose rule. The Tresiba label has a written rule for a late basal dose, and that rule belongs to Tresiba only.
This page summarizes FDA labeling. It is not personalized medical advice; confirm what to do with your prescriber or pharmacist.